Quince Therapeutics gains on buyout offer from Echo Lake Capital
** Shares of Quince Therapeutics Inc QNCX.O jump 46.1% to
$1.22 - among the biggest gainers across U.S. stock exchanges
premarket
** Biotech firm says it received a buyout offer from Echo
Lake Capital urn:newsml:reuters.com:*:nACSgkhhla
** Echo Lake Capital plans to buy company's stock for
$1.60/share, which is a premium of 88% to its last close
** QNCX is not developing or selling any drug
** QNCX was down ~95% last year
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges